‘The Trump Of Georgia’ Goes To Washington
With high-level connections in the Capitol, Parker "Pete" Petit aims to resolve regulatory issues that have haunted his wound care company.
The independent source for health policy research, polling, and news.
1,561-1,580 of 1,723 results
With high-level connections in the Capitol, Parker "Pete" Petit aims to resolve regulatory issues that have haunted his wound care company.
New research finds that the Affordable Care Act — especially the Medicaid expansion — helped about 4 million people with chronic health problems get coverage. Researchers say their findings could help Republicans planning a replacement.
President Barack Obama succeeded where many other presidents failed, but now the fate of the Affordable Care Act rests with President-elect Donald Trump.
After intense negotiations among party factions, Republican leaders unveil legislation that committees will mark up this week.
The prospect of repealing the Affordable Care Act – with no replacement ready – finds many having second thoughts.
One in four doctors practicing in the U.S. is an international medical doctor. Many foreign-born doctors practice in parts of the country where there are doctor shortages.
Remarks by Sen. Mike Lee and Reps. Jim Jordan and Mark Meadows reflect growing uncertainty about Republicans’ path to overhaul Obamacare.
The legislation is only a first step, declaring the “intent” of the state Senate without specifics or a timetable.
Some lesser known provisions of the health law — things like calorie counts, lifetime limits and breast-feeding support — could be rolled back by repeal.
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
President-elect Donald Trump says his administration will offer its plan to overhaul the federal health law once Rep. Tom Price is confirmed as the secretary of the Department of Health and Human Services.
A drug from Marathon Pharmaceuticals has ignited a firestorm on Capitol Hill and beyond. What makes it different than the $750,000 drug that came before it?
Trump opponents — and even some supporters — say the election and tumultuous early days of the new administration have left them anxious, angry and afraid of Facebook.
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
Some foreign-born California residents fear they could be penalized for using Medi-Cal and other social benefits. Others, in families of mixed-immigration status, worry about jeopardizing their loved ones’ chances of becoming green-card holders or citizens.
House Democrats start legislative work on House Speaker Nancy Pelosi’s prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trump’s health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Teachers and health professionals report post-election depression, anxiety and stress in young immigrants and minorities.
Giving consumers more knowledge about the costs of care has long been desired, but administration officials cautioned it could take two years or more for useful data to appear in a phone app.
After hearing complaints about its high price, Marathon Pharmaceuticals is pausing the launch of an $89,000 drug for a rare disease.
People who think the change in administrations may save them from having to pay a fine for not having insurance in 2016 could be in for a rude surprise.
© 2026 KFF